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A distal enhancer that speci®es apolipoprotein E
gene expression in the skin was identi®ed and char-
acterized by in situ hybridization in transgenic mice
generated with constructs of the human apolipopro-
tein E/C-I/C-IV/C-II gene cluster. Transgene con-
structs containing the enhancer expressed high levels
of apolipoprotein E mRNA in the germinative cell
layer of the sebaceous gland and in epithelial cells of
the hair follicle root sheath. Apolipoprotein E
mRNA was also detected in basal epithelial cells of
the epidermis. Expression of the human apolipopro-
tein E transgene at these sites was speci®ed by a
unique 1.0 kb enhancer domain located 1.7 kb down-
stream of the apolipoprotein E gene. No transgene
expression was detected in skin epithelial cells in
transgenic mice when this enhancer was deleted
from the apolipoprotein E gene cluster. The enhan-
cer was used to construct a transgene expression vec-
tor that faithfully directed a heterologous cDNA to
the normal sites of apolipoprotein E gene expression
in epithelial cells of the skin. Key words: apoE mRNA/
enhancer/epidermis/hair follicle/sebaceous gland/transgenic.
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A
polipoprotein E (apoE) (Mr = 35,000) has multiple
functions in lipid metabolism (Mahley, 1988; Mahley
and Huang, 1999). ApoE is a ligand for the family of
low-density lipoprotein (LDL) receptor proteins and
binds to heparan sulfate proteoglycans. Through
these properties, apoE mediates the clearance of large remnant
lipoproteins and apoE-rich high-density lipoproteins (HDLs) from
plasma, thereby functioning in the redistribution of cholesterol and
triglycerides between peripheral tissues and the liver. As much as
90% of plasma apoE is produced by the liver (Linton et al, 1991),
but the apoE gene is expressed at widely varying levels in speci®c
cells of most tissues throughout the body (Elshourbagy et al, 1985).
The presence of either arginine or cysteine at residues 112 and 158
(Weisgraber et al, 1981) speci®es three common human apoE
variants, E2, E3, and E4 (Zannis and Breslow, 1981; Sing and
Davignon, 1985), that alter apoE function. ApoE3 is the major
variant in the normolipidemic human population. ApoE2 is
defective in receptor binding and associated with type III
hyperlipidemia and premature atherosclerosis (Mahley and Rall,
1999). ApoE4 facilitates the formation of the amyloid plaques and
neuro®brillary tangles characteristic of Alzheimer's disease, making
it an important risk factor for this neurodegenerative disorder
(Roses, 1994; Weisgraber et al, 1994; Masliah et al, 1996).
Several studies have shown that apoE is produced by the skin.
The skin was identi®ed as a major site of apoE mRNA in rodents
(Elshourbagy et al, 1985; Simonet et al, 1991), and rat skin slices
synthesize and secrete apoE (Tarugi et al, 1991). Disruption of the
lipid permeability barrier in mice increases epidermal apoE mRNA
levels (Jackson et al, 1992). Mice lacking apoE develop cutaneous
foam cells, and feeding these animals a high-fat diet results in
pathologic skin lesions enriched in lipid-®lled macrophages
(Feingold et al, 1995). Isolated cultured human keratinocytes also
secrete apoE (Gordon et al, 1989). Immunohistochemical analysis
of human skin samples revealed apoE within epidermal epithelial
cells and at the basement membrane of the dermal-epidermal
junction (Furumoto et al, 1998). Immunoreactive apoE is a
component of amyloid deposits in patients with cutaneous
amyloidosis (Furumoto et al, 1998). Although these observations
suggest a link between apoE and skin disorders, a mechanism for
this association is unknown, and animal models for its study are
limited in number.
The human apoE gene is located on chromosome 19 at the 5¢
end of a 44 kb gene cluster that also contains the apoC-I, apoC-IV,
and apoC-II genes, and the apoC-I¢ pseudogene (Allan et al, 1995a;
1995b). In all tissues, apoE gene expression is controlled by cell-
speci®c distal enhancers (Taylor et al, 1991; 1993). In the absence of
these enhancers, the proximal promoter cannot direct transcription
of the apoE gene in any cell in vivo (Simonet et al, 1993).
Hepatocyte expression of apoE is controlled by two cell-speci®c
enhancers located 15 and 26 kb downstream of the apoE gene
(Simonet et al, 1993; Allan et al, 1997). The most distal liver
enhancer appears to have arisen from the evolutionary duplication
of an 11 kb genomic fragment that generated the inactive apoC-I¢
pseudogene (Allan et al, 1997). A preliminary RNase protection
analysis of tissue extracts from transgenic mice generated with apoE
gene constructs indicated that apoE expression in the skin is also
controlled by a distal downstream enhancer (Simonet et al, 1991).
The location of this enhancer, however, the cell types in which it
functions, and the possibility that more than one skin enhancer
domain might exist have not previously been determined.
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We report here on the localization of a unique cell-speci®c
enhancer domain that directs expression of the human apoE gene at
high levels in the cells of the germinative outer layer of sebaceous
glands and in epithelial cells of the hair follicle root sheath. The
enhancer also directs apoE expression in basal epithelial cells of the
epidermis. No expression of apoE in the skin occurs in the absence
of this enhancer. The enhancer is capable of directing expression of
heterologous sequences to these sites, making it a potentially useful
component of transgene vectors for targeting gene expression to
the skin.
MATERIALS AND METHODS
Transgenic mice and constructs Transgenic mice (inbred FVB/N
strain) were generated by standard techniques with constructs of the human
apoE gene cluster (Fig 1) as described previously (Allan et al, 1995b). Two
to four independent founder lines were established for each construct, and
F1 progeny were analyzed in each case: representative data for each
construct are presented here. The 70 kb 198.KK cloned genomic fragment
and the 10 kb HEG1 subfragment (Fig 1) have been described previously
(Simonet et al, 1993; Allan et al, 1995a). The 10 kb HESS1 subfragment was
generated by SphI digestion of apoE gene cluster DNA. The 198.SA
construct was generated by deleting the 1.0 kb fragment between HindIII
sites, located 1.7 and 2.7 kb downstream of the apoE gene in the 198.KK
clone, by recA-assisted restriction endonuclease (RARE) cleavage methods
as described previously (Allan et al, 1997). To make the HEG2.6 construct,
a 2.6 kb fragment from the apoE/C-I intergenic region was generated by
polymerase chain reaction extension of oligonucleotides corresponding to
the intergenic region from 2.7 kb downstream of the apoE gene to the 3¢
end of the apoC-I promoter. The 2.6 kb fragment then was ligated to the 3¢
end of construct HEG.1.
To test skin enhancer activity, we modi®ed a transgene expression vector
(Fan et al, 1994) constructed with sequences from the human apoE gene.
The vector apoE gene sequences included 3.0 kb of 5¢ ¯anking sequence,
the ®rst exon, the ®rst intron, and six nucleotides of the second exon
ligated to a polylinker that serves as a cDNA insertion site. The cDNA site
was followed by the 3¢ terminal 124 nucleotides of the human apoE gene
fourth exon, and 112 nucleotides of 3¢ ¯anking sequence ligated to a
polylinker into which the skin enhancer domain was inserted. Additional
polylinker sites added to both ends of the construct permit insertion into
and excision from plasmids. An enhanced green ¯uorescent protein (GFP)
cDNA (EGFP, Stratagene, La Jolla, CA) was inserted into the cDNA site to
generate a basic reporter construct. To direct transgene expression to the
skin, transgene vector pEGFPsk, the 1.0 kb HindIII fragment from the
apoE/C-I intergenic region, was inserted into the 3¢ polylinker of the basic
reporter construct.
Nucleotide sequences were evaluated by the ClustalW algorithm and the
Pustell matrix algorithm in the MacVector software suite (Oxford
Molecular, Beaverton, OR). The human involucrin promoter sequence
was taken from GenBank AF085346. The human apoE gene cluster
nucleotide sequences were taken from GenBank AF050154 and our own
sequence analysis (data not shown).
In situ hybridization Skin samples from the tail and ear were excised,
placed in 4% paraformaldehyde, incubated overnight at 4°C, and
embedded in paraf®n; 7 mm sections were cut by rotary microtome,
mounted on Superfrost Plus slides (Fisher, Pittsburgh, PA), and baked at
55°C for 30 min. After removal of paraf®n by two successive 10 min
immersions in xylene, the tissue sections were rehydrated in a progressive
series of 3 min washes in 100%, 90%, 70%, 50%, and 30% ethanol, followed
by three successive 5 min immersions in phosphate-buffered saline (PBS)
(137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4,
pH 7.3). The sections were incubated in 20 mg per ml proteinase K
(Boehringer Mannheim, Indianapolis, IN) in 50 mM Tris-HCl, pH 8.0,
5 mM ethylenediamine tetraacetic acid (EDTA), 150 mM NaCl for 15 min
at 20°C; proteolytic activity was stopped by immersion for 10 min in 0.2%
glycine in PBS. After rinsing in PBS for 5 min, tissues were ®xed in 4%
paraformaldehyde for 5 min, rinsed in PBS for 5 min, and acetylated for
10 min with 0.25% acetic anhydride in 0.1 mM triethanolamine, pH 8.0.
Tissue sections were rinsed for 5 min in PBS and dehydrated by 3 min
washes in 30%, 50%, 80%, 95%, and 100% ethanol.
RNA probes complementary to nucleotides 492-783 of mouse apoE
mRNA and 20-411 of human apoE mRNA were labeled with [a-
33P]UTP to a speci®c activity of at least 2 3 104 Ci per mmol with an
RNA transcription kit (Stratagene). Both antisense and sense probes were
prepared and used. Labeled probes were puri®ed through Micro Bio-Spin
30 chromatography columns (BioRad, Hercules, CA).
Tissue sections were incubated with 2.0 3 106 cpm of hybridization
probe for 14-18 h at 42°C in 50% formamide, 300 mM NaCl, 5 mM
EDTA, 1 3 Denhardt's solution (0.2% polyvinylpyrrolidone, 0.02% Ficoll,
0.02% bovine serum albumin), 10% dextran sulfate, 250 mg per ml salmon
sperm DNA, 0.1 mg per ml tRNA, and 20 mM Tris, pH 8.0. Then they
were incubated twice for 10 min each at 20°C in 2 3 salt sodium citrate
(SSC) (30 mM NaCl, 3 mM sodium citrate) and 1.0 mM EDTA. After
immersion for 1 h at 37°C in 500 mM NaCl, 10 mM Tris, pH 8.0,
containing 20 mg per ml RNase A (Sigma, St. Louis, MO) and 10 units
per ml T1 RNase (Boehringer Mannheim), the sections were washed at
55°C in six changes of 0.1 3 SSC containing 1.0 mM EDTA for 4 h, rinsed
twice for 10 min each in 0.5 3 SSC, then dehydrated by 2 min progressive
washes in 50%, 70%, and 90% ethanol containing 0.3 M ammonium
acetate. The slides were dipped in NTB2 nuclear track emulsion (Kodak,
Rochester, NY), incubated at 4°C for 5 d, and developed with D-19
developer (Kodak). The sections were stained with hematoxylin and eosin
or methyl green as described previously (Simonet et al, 1993) and overlaid
with coverslips. Hybridization of a probe to mRNA was detected by dark-
®eld microscopy. No signal was detected in the skin when a labeled sense
probe was used for hybridization.
Cellular localization studies Immunocytochemistry was done with
rabbit antihuman apoE essentially as described by Boyles et al (1985). The
antibody to human apoE was a gift from Dr. Karl Weisgraber (Gladstone
Institute of Cardiovascular Disease). Sections expressing GFP were
examined by ¯uorescence microscopy at 480 nm, and potential
auto¯uorescence was evaluated at 520 nm.
RESULTS
To identify the cells that expressed the human apoE gene in the
skin, we performed in situ hybridization with a radioactive human
apoE antisense probe on samples from transgenic mice generated
with the 198.KK cloned human genomic fragment (Fig 1). Dark-
Figure 1. Transgenic constructs of the human
apoE gene cluster. The horizontal lines repre-
sent construct lengths, and the apo genes in the
cluster are illustrated; solid vertical lines indicate
exons and open boxes indicate introns. Transcrip-
tion of each gene is in the 5¢ to 3¢ orientation. All
DNA lengths are given in kb. The hepatic control
regions, HCR.1 and HCR.2, are shown for refer-
ence, and they are indicated by shaded ovals. The
location of the skin enhancer is indicated by a
dark oval. The 1.0 kb HindIII/HindIII intergenic
domain as illustrated by the V-shaped line was de-
leted from the 198.SA construct, and it is not in-
cluded in the HEG2.6 construct.
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®eld microscopy showed that the hybridization signal was
concentrated most strongly over the germinative cells constituting
the outer layer of sebaceous glands (Fig 2A). A weak hybridization
signal was detected in the basal epithelium of the epidermis.
To determine the location of the epithelial regulatory sequences,
we investigated the ability of subfragments of the gene cluster
(Fig 1) to direct apoE expression to the skin. No hybridization of
the human antisense apoE probe was observed in skin sections from
transgenic mice generated with the HEG1 subfragment (Fig 2B),
indicating that expression of the apoE gene in the skin is likely to be
directed by enhancer sequences located further downstream. The
lack of a signal also demonstrated that there was no signi®cant
cross-hybridization of the human apoE mRNA probe to
endogenous mouse apoE mRNA. Hybridization of the human
apoE probe to skin from HESS1 transgenic mice gave a strong
positive signal in sebaceous glands and hair follicle epithelium and a
weaker signal in the basal epithelium of the epidermis (Fig 2C).
The apoE mRNA signal in the epidermis varied in intensity
(Fig 2A, C), consistent with previously reported heterogeneity in
the basal epithelial cell population (Milstone and LaVigne, 1985). A
similar ®nding has been reported recently in cells of the basal
epithelial layer for the expression of genes that are under the
control of the LEF family of DNA binding proteins (DasGupta and
Fuchs, 1999). The basis for this heterogeneity is unclear, but it may
re¯ect transient differences in the proliferation potential of the basal
epithelia (Jones, 1997), a property that may have features in
common with the cyclic activation of hair follicle stem cells
(Cotsarelis et al, 1990; Hardy, 1992).
Transgene expression in the skin was con®rmed by immuno-
cytochemical analysis of skin sections from HESS1 transgenic mice.
Antibodies to human apoE showed immunoreactive apoE
associated with the germinative cells at the outer layer of the
sebaceous glands (Fig 3A). An immunoreactive signal was detected
in the epidermis as well, being most prominent in the spinous
epithelial layer. No immune cross-reaction was detected between
the antihuman apoE and endogenous mouse apoE in nontransgenic
control mice (Fig 3B).
The apoE/C-I intergenic region was examined further to
localize the skin enhancer element. The presence of HindIII
restriction endonuclease sites at 1.7 and 2.7 kb downstream of the
apoE gene permitted the excision of this 1.0 kb fragment from the
198.KK genomic clone by the RARE cleavage method (Allan et al,
1997) to generate the 198.SA construct (Fig 1). Analysis of skin
from 198.SA transgenic mice by in situ hybridization showed no
reaction of the human apoE antisense probe with sebaceous glands,
hair follicle epithelium, or the epidermis (Fig 2D). Similarly, the
HEG2.6 construct that lacked the same 1.0 kb HindIII fragment
but contained the remainder of the apoE/C-I intergenic region was
not expressed in the skin (Fig 2E). These results indicated that the
skin enhancer was located in the 1.0 kb HindIII/HindIII portion of
the intergenic region. Furthermore, the lack of a hybridization
signal at these sites in the 198.SA transgenic mice indicated that no
other skin enhancer was located within or near the human apoE
gene cluster.
The location of the skin enhancer in the 1.0 kb HindIII/HindIII
portion of the apoE/C-I intergenic region was con®rmed by
preparing a transgene expression vector, pEGFPsk (Fig 4), that used
GFP as a sensitive reporter gene for ease of detection. Examination
of skin from pEGFPsk transgenic mice by ¯uorescence microscopy
showed an intense signal in the sebaceous gland germinative cells
and in the epithelial cells of both the inner and outer root sheath of
the hair follicle (Fig 5A-C). A somewhat weaker signal was
observed in the epidermis. In the absence of the 1.0 kb HindIII
intergenic fragment, the parent GFP expression vector was not
expressed in any cells in the skin (data not shown).
The tissue speci®city of the apoE skin enhancer was investigated
further by examining the potential expression of the EGFP
transgene reporter construct in various tissues of transgenic mice
generated with the pEGFPsk vector (Fig 4). The highly sensitive
¯uorescence microscopy assay detected no GFP signal in any tissue
examined other than skin and kidney (Fig 6). Sections from
submaxillary gland, lung, and choroid plexus were examined
because of their relative enrichment in epithelial cells with
distinctly different phenotypic properties. In the absence of the
Figure 2. Distribution of expression of apoE mRNA in control and transgenic mouse skin. Sections from the tail skin of transgenic mice are
shown after hybridization with the human apoE antisense 33P-labeled probe as visualized by dark-®eld microscopy (A, B, D, and E) or bright-®eld
microscopy (C). Scale bar: 200 mm. Silver grains scattered over cells (white grains in dark-®eld and dark grains in bright-®eld) denote a positive signal for
apoE mRNA. The germinative outer layer of sebaceous glands (SG) and basal epithelia (BE) of the epidermis are indicated. Constructs used to generate the
transgenic mice were (A) 198.KK, (B) HEG1, (C) HESS1, (D) 198.SA, (E) HEG2.6.
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skin enhancer, the GFP reporter construct is not expressed in the
skin (Fig 5D). These results (Fig 6) and the data shown in Fig 5
and Fig 2 indicate that the activity of the apoE skin enhancer may
be speci®c to epithelial cells in the germinative layer of the
sebaceous glands and to cells in the basal and spinous layers of the
epidermis.
In the absence of the skin enhancer, expression of the GFP
reporter construct was observed in the kidney (Fig 6C). Transgene
expression was restricted to epithelial cells lining Bowman's capsule
and a limited population of nearby tubules. This pattern of GFP
transgene expression is essentially the same as that shown by the
native HEG1 genomic fragment containing the intact human apoE
gene with 5.3 kb of 5¢ ¯anking sequence and 1.7 kb of 3¢ ¯anking
sequence (Fig 6I). These results are consistent with our previous
®ndings in which we demonstrated that HEG1 expression occurs at
high levels in only the epithelial cells lining Bowman's capsule and
the proximal tubules (W Simonet 10809, W Simonet 8221). Our
results here are consistent with the location of kidney enhancer
activity in the proximal 5¢ ¯anking region of the apoE gene or
within its ®rst intron. The skin enhancer is located more than
1.7 kb downstream of the apoE gene. The skin enhancer does not
contribute to epithelial cell expression in the kidney nor does it
direct transgene expression to epithelial cells in any other tissue
examined.
DISCUSSION
Our results demonstrate that a single skin enhancer domain located
1.7 kb downstream of the apoE gene is solely responsible for
directing expression of the apoE gene to the skin. No evidence for
any other skin enhancer was found within a 70 kb cloned human
genomic segment that included 5 kb of 5¢ ¯anking sequence
upstream of the apoE gene, the entire apoE gene cluster, and
~21 kb of 3¢ ¯anking sequence downstream of the apoC-II gene. In
the absence of the enhancer, the apoE promoter was not
transcriptionally active in the skin. The enhancer was most active
in the germinative outer cell layer of sebaceous glands and in basal
epithelial cells of the hair follicle root sheath. These sites of apoE
production have not previously been reported.
We examined the nucleotide sequence of the 1.0 kb HindIII
apoE gene skin enhancer domain in the apoE/C-I intergenic
region. The 3¢ half contained an intact member of the 0.3 kb Alu
repeat family ¯anked by two partial Alu family repeated sequences
(data not shown). The 5¢ half of the enhancer domain consisted of a
unique sequence (Fig 7) that had no signi®cant homology to any
other domain within the human apoE gene cluster as determined
by sequence analysis with the ClustalW alignment and Pustell
matrix algorithms. Similarly, no region homologous to the unique
sequence in the 1.0 kb HindIII skin enhancer domain was detected
in the known 17 kb sequence of the 5¢ ¯anking domain as reported
in Genbank (data not shown). Our analysis of the 198.SA construct
(Fig 2) suggested that no skin enhancer element is located within
21 kb of the 3¢ ¯anking domain of the gene cluster. Thus, the
unique sequence located between 1.7 kb and 2.3 kb downstream of
the apoE gene appears to be the only skin enhancer domain
associated with the human apoE gene cluster.
ApoE mRNA is most abundant in the basal layer of the
epidermis, a site that is relatively enriched in LDL receptors
(Williams et al, 1987; Mommaas et al, 1991). These receptors have a
high af®nity for apoE (Mahley, 1988), and they may function in the
uptake of circulating interstitial lipoproteins. The HDLs constitute
the predominant lipoprotein class in interstitial ¯uid, and apoE is a
principal component of the large HDLs in this ¯uid (Vessby et al,
1987). The suprabasal layer of cells in the epidermis has a reduced
content of LDL receptors (Williams et al, 1987). Compared with
the basal layer, the suprabasal layer had less apoE mRNA but was
Figure 3. Immunocytochemical localization of human apoE in
transgenic mouse skin. Tail skin from a HESS1 transgenic mouse (A) or
control mouse (B) was reacted with an antibody to human apoE and then
with a secondary antibody to detect the location of the antihuman apoE as
described by Boyles et al (1985). The presence of apoE as a result of
transgene expression is indicated by a dark immunoprecipitate under
bright-®eld microscopy. Scale bar: 200 mm. Skin components, including
spinous epithelia (SE), basal epithelia (BE), and sebaceous glands (SG), are
labeled.
Figure 4. Skin expression vector. All sequences
between the ¯anking 5¢ and 3¢ polylinkers are de-
rived from the human apoE gene cluster except
for the inserted synthetic polylinker sites and the
GFP reporter cDNA.
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Figure 5. Reporter gene expression in the
skin of transgenic mice is directed by the
apoE skin enhancer. The expression of the GFP
reporter construct in transgenic mice generated
with the vector illustrated in Fig 4 was analyzed
by ¯uorescence microscopy. (A) Section of tail
skin showing sebaceous glands (SG), hair follicles
(HF), and the epidermis (E). (B) Hair follicles
from the tail skin are shown showing the hair
shaft (H), inner root sheath (IRS), and outer root
sheath (ORS). (C) A section from the ear skin
having a transgene signal in sebaceous glands (SG)
and the epidermis (E) is shown. Fluorescence mi-
croscopy of a section of tail skin from transgenic
mice generated with the EGF reporter construct
lacking the skin enhancer showed only limited
auto¯uorescence of the hair shaft (not shown).
Scale bar: (A,C) 180 mm, (B) 200 mm.
Figure 6. Examination of reporter gene expression in different tissues of transgenic mice. Transgene expression in tissues excised from transgenic
mice that were generated with the GFP reporter vector illustrated in Fig 4 was analyzed by ¯uorescence microscopy (A, C, D, and G) and phase contrast
microscopy. Scale bar: 200 mm. (B, E, F, and H). Scale bar: 200 mm. (A), (B) Submaxillary gland; (D), (E) lung; (G), (H) choroid plexus from the fourth
ventricle of the brain; (C), (F) kidney. Panel I shows a section of the kidney from a transgenic mouse generated with the HEG1 construct that was examined
by in situ hybridization and bright-®eld microscopy with a human apoE mRNA antisense probe as described in the text.
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relatively enriched in immunoreactive apoE (Fig 3A). This ®nding
suggests that much of the newly synthesized apoE remains
associated with the suprabasal epithelial layers where it may
function to supply lipid components in response to a substantially
increased need by differentiating keratinocytes. Our localization of
apoE mRNA in the epidermis is consistent with the results of a
previous RNase protection analysis of total RNA extracted from
cultured keratinocytes that were derived from a human adult male
(Barra et al, 1994). These earlier studies concluded that basal
epithelia are rich in apoE mRNA that is translated into secretable
apoE protein. Our ®nding that abundant amounts of immunor-
eactive apoE are associated with spinous epithelia, however,
appears to be in contrast with the earlier studies (Barra et al,
1994), which reported that large cultured suprabasal epithelial cells
contain substantial levels of apoE mRNA but are de®cient in apoE
synthesis and secretion. This variance between our study of
transgenic mice and the previous study of cultured cells may be a
re¯ection of the differences in metabolic and regulatory signals
likely to be acting on differentiating epithelia in in vivo and in vitro
environments.
Mature keratinocytes had no detectable apoE mRNA or
immunoreactive apoE protein. As epidermal cells mature into
keratinocytes, LDL receptors are lost and there is an increase in the
synthesis of endogenous lipids (Williams et al, 1987), including
ceramides and cholesterol, which become major components of the
skin lipid barrier (Downing, 1992). In the highly strati®ed
environment of the skin, apoE may be important in delivering
lipids for use in membrane assembly during cell division. Portions
of these lipids may serve as substrates for the synthesis of various
components of the surface lipid barrier. Consistent with this
possibility is the observation that damage or removal of the lipid
barrier results in an increase in epidermal apoE mRNA levels
(Jackson et al, 1992). Thus, apoE production may contribute to
maintenance and replenishment of skin surface lipids. This effect
may be indirect, with apoE supplying lipid to rapidly growing basal
epithelium for subsequent utilization by keratinocytes in the
synthesis of lipids that become part of the epidermal surface.
The distribution of apoE gene expression in the skin contrasts
with that of the involucrin gene, a marker for large mature
differentiated keratinocytes that is not expressed in small basal
epithelia (Banks-Schlegel and Green, 1981; Watt and Green, 1981).
Both apoE and involucrin are expressed at abundant levels in
suprabasal epithelia and in inner root sheath epithelia, however; and
a 2.5 kb involucrin promoter construct has been used to target a
heterologous transgene to these sites (Pelengaris et al, 1999). To
determine if this pattern of gene expression involved regulatory
elements in common, we compared the nucleotide sequence of the
apoE skin enhancer with that of the proximal 2.5 kb of the 5¢
¯anking region of the involucrin gene (Crish et al, 1998). A
sequence identity of ~40% was found between the two enhancers
that corresponded to nucleotides ±1951 and ±2404 upstream of the
involucrin gene (Fig 7). Although the sequence similarity is
limited, the alignment is consistent with previous studies that
reported that regulatory elements in the region between ±1951 and
±2473 upstream of the involucrin gene were required for its
expression in the epidermis (Crish et al, 1998). No involucrin
expression in the skin occurred in the absence of this enhancer
(Crish et al, 1998). As the apoE and involucrin enhancers have
regions of notable sequence homology, it is likely that common
elements outlined by the larger shaded boxes in Fig 7 direct gene
expression to the skin. No consensus currently exists, however,
regarding the identity of any unique transcription factor or
combination of factors that speci®es epithelial expression in this
tissue (Byrne, 1997). Functional tests remain to be performed to
assess this possibility.
ApoE mRNA was detected at high levels in the germinative
outer layer of the sebaceous glands, a layer of cells that also is in
contact with interstitial ¯uid. As these cells differentiate, their
progeny are displaced into the inner layers of the gland, where they
synthesize characteristic lipids of the sebum that are distinct from
epidermal lipids (Stewart and Downing, 1991). These sebaceous
cells become larger and engorged with lipids. Sebaceous cells live
about 5 d in rodents (Colton and Downing, 1985); when they die,
cellular lipids are released into the sebum. As the sebum empties
into the hair follicle, it acts as a dynamic seal around the hair shaft
and contributes to body scent (Stewart and Downing, 1991).
The action of apoE in delivering interstitial lipids to the
sebaceous gland may be in a dynamic balance with the opposing
action of apoC-I. Transgenic mice that overexpress apoC-I have
cutaneous abnormalities, including atrophic sebaceous glands,
reduced sebum production, partial hair loss, and scaly skin (Jong
et al, 1998). ApoC-I inhibits the binding of apoE to cell-surface
receptors, thereby reducing apoE-mediated uptake of lipoproteins
into cells (Weisgraber et al, 1990; Swaney and Weisgraber, 1994).
These observations suggest that delivery of apoE to sebaceous
glands may be regulated and responsive to physiologic signals.
Furthermore, impairment of apoE-mediated lipid delivery to
sebaceous glands may lead to skin disorders that affect the
protective nature of sebum.
The cellular locations of apoE mRNA in the skin suggest that a
major function of apoE in this tissue is to deliver lipids for the
accelerated production of new cells, which requires substantial
amounts of new membrane synthesis. This possibility is consistent
with the hypothesis that apoE plays a role in mobilizing membrane
lipids during nerve regeneration (Boyles et al, 1990), synaptic
remodeling (Poirier, 1994), and neurite outgrowth (Handelmann
Figure 7. Nucleotide sequence of the apoE
gene skin enhancer. The 5¢ and 3¢ termini of
the unique sequence region in the human apoE
gene skin enhancer domain are located at nucleo-
tides 1749 and 2204, respectively, downstream of
the fourth exon of the gene. These compare to
nucleotides ±2404 to ±1951 upstream of the hu-
man involucrin (Invo) gene. Shaded boxes indi-
cate regions of sequence identity.
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et al, 1992). The rapid growth of new cells in the germinative layer
of sebaceous glands would be expected to create a high demand for
new membrane lipids, and that is where the highest levels of apoE
mRNA are found in the skin. Reduction in the apoE-mediated
delivery of lipid to sebaceous glands would be expected to impair
gland differentiation and the production of sebum. In the
epidermis, the synthesis of apoE in basal epithelial cells would
facilitate new cell membrane production, but intracellular meta-
bolic requirements may also contribute to apoE production in this
location (Barra et al, 1994). In zebra-®sh, apoE mRNA is present at
high levels in the epithelial cells of pectoral limb buds and median
®n fold during embryogenesis and in the basal cell layer of the
epidermis at sites of ®n and scale development during ®n
regeneration (Monnot et al, 1999). These sites of synthesis support
a role for apoE in tissue development.
ApoE may play a role in delivering lipid from interstitial
lipoproteins to sebaceous glands and the epidermis for the synthesis
of key components in the skin surface lipid barrier. It remains to be
determined whether this effect of apoE is an indirect result of
facilitating new cell production or a direct effect of supplying new
lipid for endogenous lipid synthesis. Our ®ndings in this study
indicate that apoE is a key mediator in the redistribution of
cholesterol and other lipids in the skin that are essential for
membrane remodeling and cell growth. Knowledge of the
regulatory sequences that specify apoE expression at those sites
and the availability of transgene expression vectors that target to
those sites should help to elucidate the physiologic mechanisms that
utilize apoE in the skin.
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